RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513,558 | -11.1% | 30,900 | 0.0% | 0.00% | – |
| Q2 2023 | $577,830 | +1.9% | 30,900 | 0.0% | 0.00% | – |
| Q1 2023 | $567,015 | -7.3% | 30,900 | 0.0% | 0.00% | – |
| Q4 2022 | $611,820 | -9.5% | 30,900 | +10.0% | 0.00% | – |
| Q3 2022 | $676,000 | +31.8% | 28,100 | 0.0% | 0.00% | – |
| Q2 2022 | $513,000 | -17.0% | 28,100 | 0.0% | 0.00% | – |
| Q1 2022 | $618,000 | -39.9% | 28,100 | +0.4% | 0.00% | – |
| Q4 2021 | $1,028,000 | +18.3% | 28,000 | 0.0% | 0.00% | – |
| Q3 2021 | $869,000 | -2.4% | 28,000 | 0.0% | 0.00% | – |
| Q2 2021 | $890,000 | +174.7% | 28,000 | +91.8% | 0.00% | – |
| Q1 2021 | $324,000 | +12.5% | 14,600 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | -38.7% | 14,600 | 0.0% | 0.00% | – |
| Q3 2020 | $470,000 | +22.7% | 14,600 | +10.6% | 0.00% | – |
| Q2 2020 | $383,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |